Effects of green coffee supplementation on paraoxonase-1 activity and malondialdehyde levels in Iranian women with polycystic ovary syndrome: a randomized clinical trial

Objectives Polycystic ovary syndrome (PCOS) is a common, heterogeneous clinical syndrome affecting women. Investigating oxidative stress in women is crucial, as it is linked to insulin resistance and endothelial dysfunction. Chlorogenic acid, a bioactive component found in green coffee, has numerous...

Full description

Saved in:
Bibliographic Details
Main Authors: Azam Ildarabadi, Marzieh Vahid-Dastjerdi, Mina Ghorbanpour, Ahmad Mousavi, Mehrnoush Meshkani, Mirsaeed Yekaninejad, Ahmad Saedisomeolia
Format: Article
Language:English
Published: Korea Disease Control and Prevention Agency 2024-12-01
Series:Osong Public Health and Research Perspectives
Subjects:
Online Access:http://ophrp.org/upload/pdf/j-phrp-2024-0187.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849772582154272768
author Azam Ildarabadi
Marzieh Vahid-Dastjerdi
Mina Ghorbanpour
Ahmad Mousavi
Mehrnoush Meshkani
Mirsaeed Yekaninejad
Ahmad Saedisomeolia
author_facet Azam Ildarabadi
Marzieh Vahid-Dastjerdi
Mina Ghorbanpour
Ahmad Mousavi
Mehrnoush Meshkani
Mirsaeed Yekaninejad
Ahmad Saedisomeolia
author_sort Azam Ildarabadi
collection DOAJ
description Objectives Polycystic ovary syndrome (PCOS) is a common, heterogeneous clinical syndrome affecting women. Investigating oxidative stress in women is crucial, as it is linked to insulin resistance and endothelial dysfunction. Chlorogenic acid, a bioactive component found in green coffee, has numerous documented health benefits. This study aimed to assess the beneficial effects of green coffee consumption on paraoxonase-1 (PON-1) activity and malondialdehyde (MDA) levels in women with PCOS. Methods This study was a double-blind randomized clinical trial that included 44 patients with PCOS. Participants were randomly assigned to either the intervention or control group. For 6 weeks, the intervention group (n=22) received 400 mg of green coffee supplements, while the control group (n=22) received 400 mg of a starch-based placebo. Anthropometric indices, dietary assessments, and physical activity levels were evaluated before and after the 6-week intervention period. Additionally, blood samples were collected for laboratory analysis. Results Supplementation with green coffee increased PON-1 levels by 3.5 units, a significant finding (p=0.038). Additionally, the intake of green coffee supplements significantly reduced blood cholesterol levels by 18.8 units (p=0.013) and triglyceride levels by 6.1 units (p=0.053). However, no significant differences were observed in the levels of MDA, high-density lipoprotein, low-density lipoprotein, fasting blood sugar, insulin, or homeostatic model assessment of insulin resistance as a result of the intervention. Conclusion Supplementation with green coffee alters PON-1 activity and cholesterol levels in women with PCOS. However, it has no significant impact on MDA levels or glycemic status.
format Article
id doaj-art-2572e2f72f5243ff8e1cbf81be6d9c13
institution DOAJ
issn 2233-6052
language English
publishDate 2024-12-01
publisher Korea Disease Control and Prevention Agency
record_format Article
series Osong Public Health and Research Perspectives
spelling doaj-art-2572e2f72f5243ff8e1cbf81be6d9c132025-08-20T03:02:18ZengKorea Disease Control and Prevention AgencyOsong Public Health and Research Perspectives2233-60522024-12-0115652153210.24171/j.phrp.2024.0187804Effects of green coffee supplementation on paraoxonase-1 activity and malondialdehyde levels in Iranian women with polycystic ovary syndrome: a randomized clinical trialAzam Ildarabadi0Marzieh Vahid-Dastjerdi1Mina Ghorbanpour2Ahmad Mousavi3Mehrnoush Meshkani4Mirsaeed Yekaninejad5Ahmad Saedisomeolia6 Department of Nutrition Science, Science and Research Branch, Faculty of Medical Science and Technology, Islamic Azad University, Tehran, Iran Department of Obstetrics and Gynecology, School of Medicine, Tehran University of Medical Science, Tehran, Iran University Research and Development Center, Tehran University of Medical Sciences, Tehran, Iran Department of Nutrition Science, Science and Research Branch, Faculty of Medical Science and Technology, Islamic Azad University, Tehran, Iran Department of Nutrition Science, Science and Research Branch, Faculty of Medical Science and Technology, Islamic Azad University, Tehran, Iran Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Science, Tehran, Iran Higher Education College of Health Sciences, Education Centre of Australia, Parramatta, NSW, AustraliaObjectives Polycystic ovary syndrome (PCOS) is a common, heterogeneous clinical syndrome affecting women. Investigating oxidative stress in women is crucial, as it is linked to insulin resistance and endothelial dysfunction. Chlorogenic acid, a bioactive component found in green coffee, has numerous documented health benefits. This study aimed to assess the beneficial effects of green coffee consumption on paraoxonase-1 (PON-1) activity and malondialdehyde (MDA) levels in women with PCOS. Methods This study was a double-blind randomized clinical trial that included 44 patients with PCOS. Participants were randomly assigned to either the intervention or control group. For 6 weeks, the intervention group (n=22) received 400 mg of green coffee supplements, while the control group (n=22) received 400 mg of a starch-based placebo. Anthropometric indices, dietary assessments, and physical activity levels were evaluated before and after the 6-week intervention period. Additionally, blood samples were collected for laboratory analysis. Results Supplementation with green coffee increased PON-1 levels by 3.5 units, a significant finding (p=0.038). Additionally, the intake of green coffee supplements significantly reduced blood cholesterol levels by 18.8 units (p=0.013) and triglyceride levels by 6.1 units (p=0.053). However, no significant differences were observed in the levels of MDA, high-density lipoprotein, low-density lipoprotein, fasting blood sugar, insulin, or homeostatic model assessment of insulin resistance as a result of the intervention. Conclusion Supplementation with green coffee alters PON-1 activity and cholesterol levels in women with PCOS. However, it has no significant impact on MDA levels or glycemic status.http://ophrp.org/upload/pdf/j-phrp-2024-0187.pdfchlorogenic acidglycemic indexgreen coffeelipid profilepolycystic ovary syndrome
spellingShingle Azam Ildarabadi
Marzieh Vahid-Dastjerdi
Mina Ghorbanpour
Ahmad Mousavi
Mehrnoush Meshkani
Mirsaeed Yekaninejad
Ahmad Saedisomeolia
Effects of green coffee supplementation on paraoxonase-1 activity and malondialdehyde levels in Iranian women with polycystic ovary syndrome: a randomized clinical trial
Osong Public Health and Research Perspectives
chlorogenic acid
glycemic index
green coffee
lipid profile
polycystic ovary syndrome
title Effects of green coffee supplementation on paraoxonase-1 activity and malondialdehyde levels in Iranian women with polycystic ovary syndrome: a randomized clinical trial
title_full Effects of green coffee supplementation on paraoxonase-1 activity and malondialdehyde levels in Iranian women with polycystic ovary syndrome: a randomized clinical trial
title_fullStr Effects of green coffee supplementation on paraoxonase-1 activity and malondialdehyde levels in Iranian women with polycystic ovary syndrome: a randomized clinical trial
title_full_unstemmed Effects of green coffee supplementation on paraoxonase-1 activity and malondialdehyde levels in Iranian women with polycystic ovary syndrome: a randomized clinical trial
title_short Effects of green coffee supplementation on paraoxonase-1 activity and malondialdehyde levels in Iranian women with polycystic ovary syndrome: a randomized clinical trial
title_sort effects of green coffee supplementation on paraoxonase 1 activity and malondialdehyde levels in iranian women with polycystic ovary syndrome a randomized clinical trial
topic chlorogenic acid
glycemic index
green coffee
lipid profile
polycystic ovary syndrome
url http://ophrp.org/upload/pdf/j-phrp-2024-0187.pdf
work_keys_str_mv AT azamildarabadi effectsofgreencoffeesupplementationonparaoxonase1activityandmalondialdehydelevelsiniranianwomenwithpolycysticovarysyndromearandomizedclinicaltrial
AT marziehvahiddastjerdi effectsofgreencoffeesupplementationonparaoxonase1activityandmalondialdehydelevelsiniranianwomenwithpolycysticovarysyndromearandomizedclinicaltrial
AT minaghorbanpour effectsofgreencoffeesupplementationonparaoxonase1activityandmalondialdehydelevelsiniranianwomenwithpolycysticovarysyndromearandomizedclinicaltrial
AT ahmadmousavi effectsofgreencoffeesupplementationonparaoxonase1activityandmalondialdehydelevelsiniranianwomenwithpolycysticovarysyndromearandomizedclinicaltrial
AT mehrnoushmeshkani effectsofgreencoffeesupplementationonparaoxonase1activityandmalondialdehydelevelsiniranianwomenwithpolycysticovarysyndromearandomizedclinicaltrial
AT mirsaeedyekaninejad effectsofgreencoffeesupplementationonparaoxonase1activityandmalondialdehydelevelsiniranianwomenwithpolycysticovarysyndromearandomizedclinicaltrial
AT ahmadsaedisomeolia effectsofgreencoffeesupplementationonparaoxonase1activityandmalondialdehydelevelsiniranianwomenwithpolycysticovarysyndromearandomizedclinicaltrial